The Recombinant BCG ΔureC∷hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflamma...
The Recombinant BCG ΔureC∷hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation
About this item
Full title
Author / Creator
Publisher
United States: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
United States: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Background. The recombinant BCG ΔureC::hly (rBCG) vaccine candidate induces improved protection against tuberculosis over parental BCG (pBCG) in predinical studies and has successfully completed a phase 2a clinical trial. However, the mechanisms responsible for the superior vaccine efficacy of rBCG are still incompletely understood. Here, we invest...
Alternative Titles
Full title
The Recombinant BCG ΔureC∷hly Vaccine Targets the AIM2 Inflammasome to Induce Autophagy and Inflammation
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1827890099
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1827890099
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1093/infdis/jiu675
